LY117018, A SELECTIVE ESTROGEN-RECEPTOR MODULATOR (SERM) IN THE OVARIECTOMIZED RAT

被引：0

作者：

BRYANT, HU ^{[1
]}

MAGEE, DE ^{[1
]}

COLE, HW ^{[1
]}

ROWLEY, ER ^{[1
]}

WILSON, PK ^{[1
]}

ADRIAN, MD ^{[1
]}

CULLINAN, GJ ^{[1
]}

YANG, NN ^{[1
]}

GLASEBROOK, AL ^{[1
]}

SATO, M ^{[1
]}

机构：

[1] ELI LILLY & CO,LILLY RES LAB,INDIANAPOLIS,IN 46285

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 1995年 / 10卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S459 / S459

页数：1

共 50 条

[21] Molecular mechanisms of selective estrogen receptor modulator (SERM) action [J].

Dutertre, M ;

Smith, CL .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (02) :431-437

[22] Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts [J].

Schafer, JM ;

Lee, ES ;

Dardes, RC ;

Bentrem, D ;

O'Regan, RM ;

Reyes, AD ;

Jordan, VC .

CLINICAL CANCER RESEARCH, 2001, 7 (08) :2505-2512

[23] Another Selective Estrogen-Receptor Modulator for Osteoporosis [J].

Becker, Carolyn .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) :752-754

[24] A conformationally restricted analog of raloxifene, LY357489, is a highly potent selective estrogen receptor modulator (SERM). [J].

Grese, TA ;

Adrian, MD ;

Bryant, HU ;

Cole, HW ;

Glasebrook, AL ;

Magee, DE ;

Pell, TR ;

Philips, DL ;

Rowley, ER ;

Sato, M ;

Shetler, PK ;

Short, LL .

JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 :S426-S426

[25] Does the addition of raloxifene analogue (LY117018) allow for reduced PTH dosing during reversal of osteopenia in the ovariectomized rat? [J].

Watson, P ;

Drost, D ;

Thornton, M ;

Holdsworth, D ;

Fraher, L ;

Hodsman, A ;

Hock, J ;

Bryant, H .

JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 :F489-F489

[26] Effects of the raloxifene analog LY117018 on B-lymphopoiesis and bone loss induced by estrogen deficiency [J].

Onoe, Y ;

Miyaura, C ;

Ohta, H ;

Nozawa, S ;

Suda, T .

JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 :P263-P263

[27] UTERINE BIOASSAY OF TAMOXIFEN, TRIOXIFENE AND A NEW ESTROGEN ANTAGONIST (LY117018) IN RATS AND MICE [J].

BLACK, LJ ;

GOODE, RL .

LIFE SCIENCES, 1980, 26 (17) :1453-1458

[28] Chemoprevention of colon cancer by raloxifene, a selective estrogen receptor modulator (SERM). [J].

Rao, Chinthalapally V. ;

Janakiram, Naveena B. ;

Swamy, Malisetty V. ;

Guruswamy, Suresh ;

Patlolla, Jagan M. R. ;

Thungathurthi, Ruchita ;

Kopelovich, Levy ;

Steele, Vernon E. .

CANCER RESEARCH, 2006, 66 (08)

[29] A SERM (Selective Estrogen Receptor Modulator) Treatment Based Approach to Menopause [J].

Foreman, Heather D. ;

Thacker, Holly .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12) :1383-1383

[30] Comparison of ERA-923, a new selective estrogen receptor modulator (SERM) for the treatment of estrogen-receptor positive breast cancer, with other SERMs. [J].

Greenberger, LM ;

Komm, B ;

Miller, C ;

Annable, T ;

Lyttle, R ;

Frost, P .

CLINICAL CANCER RESEARCH, 2000, 6 :4565S-4565S

← 1 2 3 4 5 →